Virus-specific T cells are reshaping antiviral therapy by providing targeted immune restoration. Unlike conventional drugs, VSTs offer durable protection against multiple viruses simultaneously. Clinical research demonstrates their effectiveness in preventing relapse in transplant patients. Through continued innovation, Xellera Therapeutics aims to advance VST manufacturing and access... https://www.xelleratherapeutics.com/services/custom-manufacturing-services/